Mixed Deck — All CCRC Topics Flashcards

What is the purpose of a Delegation of Authority (DoA) log in a clinical trial?

Answer: To record which tasks have been assigned to qualified staff by the PI

The DoA log documents that the PI has formally assigned specific trial tasks to qualified, trained staff members and is a key GCP requirement.

A CRA calls a CRC to schedule the final monitoring visit. The sponsor requires that the PI be present. The only dates available for the CRA conflict with the PI's schedule. To prepare for the visit, the CRC should:

Answer: reschedule the visit

If the sponsor requires the Principal Investigator (PI) to be present for a final monitoring visit and the available dates conflict with the PI's schedule, the CRC's primary responsibility is to ensure compliance with the sponsor's requirements. The most appropriate action is to reschedule the visit to a time when the PI can be present. This ensures all necessary parties are available for the comprehensive review and discussion required at a close-out visit.

What is the purpose of a Corrective and Preventive Action (CAPA) plan submitted to a sponsor after a monitoring finding?

Answer: To document and resolve protocol deviations and prevent recurrence

A CAPA plan identifies the root cause of a finding and details specific steps to correct the problem and prevent it from happening again.

A subject is issued 120 tablets and is instructed to take 2 tablets 4 times a day. He returns 88 tablets on the morning of day 9 fasting for laboratory tests. What percent compliant is he?

Answer: 50%

If 92 bottles are available for the CRC to return from an initial supply of 100 bottles, it means that 8 bottles were ultimately not returned (100 - 92 = 8). This implies that despite 26 subjects being enrolled and each receiving two bottles (52 bottles dispensed), only 8 bottles were consumed or otherwise unaccounted for, with the remaining dispensed bottles being returned unused.

A participant received a study drug dose 20% higher than specified in the protocol due to a calculation error. This event is BEST classified as:

Answer: A protocol deviation requiring documentation and reporting to the sponsor

An incorrect dosing error is a protocol deviation (and likely a major one) that must be documented and reported to the sponsor and potentially the IRB.

If a sponsor places a study on clinical hold, what must the site immediately do?

Answer: Stop all study-related interventions and enrollment as directed

A clinical hold requires the site to immediately suspend enrollment and interventions as directed by the sponsor pending FDA resolution of the safety concern.

What is one way a Clinical Research Coordinator can increase their salary potential?

Answer: All of the above

Increasing salary potential for a Clinical Research Coordinator involves a multi-faceted approach. Gaining additional experience, especially in complex trials or leadership roles, directly enhances market value. Obtaining advanced certifications, such as the CCRC, demonstrates specialized knowledge and commitment, while pursuing further education like a Master's degree can open doors to higher-level positions and increased earning capacity.

What are some common career advancements for Clinical Research Coordinators?

Answer: All of the above

Clinical Research Coordinators gain valuable experience in trial management, regulatory compliance, and patient interaction, which are foundational for various advanced roles. Moving to a Clinical Research Associate (CRA) involves monitoring multiple sites, while a Clinical Trial Manager oversees entire studies. Specializing in Regulatory Affairs also leverages a CRC's understanding of compliance, making all these viable career advancements.

A clinical research study that was initially approved by a full IRB committee is approaching its one-year approval anniversary. What is the primary purpose of the IRB's continuing review for this ongoing study?

Answer: To reassess the risk-benefit ratio and ensure the continued protection of the rights and welfare of research participants.

The fundamental purpose of IRB continuing review is to ensure that the study, as it is actually being conducted, continues to meet the ethical standards and regulatory criteria for approval. This involves re-evaluating the risks and benefits based on study progress, any new information, and ensuring that protections for participants remain adequate.

A study participant completed a required blood draw 5 days outside the protocol-specified visit window. This is an example of:

Answer: A protocol deviation

Missing a required assessment window is a common type of protocol deviation that must be documented in the site's deviation log.

Which of the following is the most appropriate and GCP-compliant method for a Principal Investigator (PI) to document the assignment of study-related tasks to qualified site staff?

Answer: A signed and dated Delegation of Authority (DoA) Log specifying tasks, start/end dates, and staff qualifications.

The Delegation of Authority (DoA) Log is the standard, essential document used to formally record which study-specific duties have been assigned by the PI to specific, qualified individuals on the team. This log provides a contemporaneous record that is crucial for regulatory compliance and is often reviewed during monitoring visits and audits. Verbal agreements, informal emails, or retrospective notes are not sufficient to meet GCP standards for documenting delegation.

At the conclusion of a clinical trial, after all data has been entered, cleaned, and all queries resolved, the sponsor performs a "database lock." What is the primary significance of this action?

Answer: It prevents any further changes to the data, creating a static dataset for final statistical analysis.

A database lock is a critical milestone that marks the transition from data collection and cleaning to data analysis. Once the database is locked, no further alterations to the data are permitted, which ensures the integrity and reproducibility of the final analysis that will be used for the clinical study report and regulatory submissions.

In which setting are Clinical Research Coordinators likely to manage patient recruitment and retention?

Answer: Academic Medical Centers

Academic Medical Centers (AMCs) are often sites for investigator-initiated trials and early-phase studies, where patient recruitment and retention are particularly challenging and critical. CRCs in these settings work closely with principal investigators and patients, directly managing the complex processes of identifying eligible participants, enrolling them, and ensuring their continued engagement throughout the study. While other entities conduct trials, AMCs frequently have a direct, hands-on role in patient-facing aspects.

A participant has been enrolled in a long-term oncology trial for two years. The sponsor issues a protocol amendment that introduces a new, optional sub-study involving additional blood draws to test for a novel biomarker. What is the CRC's responsibility regarding the informed consent for this change?

Answer: Ensure the participant is re-consented using a new, IRB-approved consent form that details the optional sub-study.

Significant new information, such as additional procedures or changes in risk, requires that participants be re-consented. The CRC must use a revised, IRB-approved informed consent form to explain the changes and document the participant's willingness to continue in the trial under the new conditions.

How long must US clinical trial records generally be retained after study completion under FDA regulations?

Answer: At least 2 years after the last marketing application approval or the study is discontinued

Under 21 CFR 312.62, investigators must retain records for at least 2 years after the last marketing application approval, or if no application is filed, 2 years after study discontinuation.

Which type of protocol deviation typically requires immediate reporting to the sponsor?

Answer: Deviations that affect participant safety or data integrity

Deviations that may affect participant safety or the integrity of study data require prompt reporting to the sponsor per GCP guidelines.

What is the primary and overarching responsibility of an Institutional Review Board (IRB)?

Answer: To protect the rights and welfare of human subjects participating in research.

The fundamental mission of the IRB, as mandated by federal regulations such as 45 CFR 46 and 21 CFR 56, is to ensure the protection of the rights and welfare of human research participants. While scientific merit is considered in the risk/benefit analysis, the IRB's primary role is ethical oversight and subject protection.

What is the primary purpose of a sponsor's audit of a clinical trial site?

Answer: To independently verify that GCP and protocol requirements are being followed

Sponsor audits are independent evaluations that verify site compliance with GCP, the protocol, and applicable regulations, separate from routine monitoring.

Which of the following is a primary responsibility of the Clinical Research Coordinator (CRC) in the management of adverse events?

Answer: Ensuring accurate and timely documentation of the event in the source documents and Case Report Forms (CRFs).

The CRC plays a critical role in ensuring that all adverse events are accurately and promptly documented in the participant's source records and transcribed correctly onto the CRFs. While the CRC assists in collecting information, the Principal Investigator is ultimately responsible for the causality assessment. The sponsor, not the site CRC, is responsible for reporting SAEs to the FDA. Protocol modifications are the responsibility of the sponsor.

A CRC is transcribing a participant's weight from a source document into the Electronic Data Capture (EDC) system. The source clearly states the weight is 90.5 kg. When the CRC enters "90.5" into the weight field, an automated edit check fires a query stating, "Value is outside the expected range of 100-250. Please confirm." The CRC realizes the EDC was mistakenly programmed to expect the value in pounds (lbs). What is the most appropriate action?

Answer: Do not change the data; respond to the query stating that the value of 90.5 kg is correct per the source document and that the edit check requires review.

The fundamental rule of data entry is that the data in the Case Report Form (CRF) must accurately reflect the source document. Changing the value to fit the incorrect edit check constitutes data manipulation. The correct action is to enter the accurate data from the source, and use the query system to communicate the discrepancy and flag the system programming error to the data management team.